FDG PET and cognitive symptoms of dementia

Clinical and Translational Imaging

Volumn 1, Issue 4, 2013, Pages 247-260

  Perani, Daniela ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Brain reserve; Cognitive decline; Cognitive functions; Dementia; Diagnosis; FDG PET

Indexed keywords

ALZHEIMER DISEASE; APHASIA; COGNITIVE RESERVE; COMPUTER ASSISTED TOMOGRAPHY; DEMENTIA; DEPTH PERCEPTION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FOLLOW UP; FRONTOTEMPORAL DEMENTIA; HUMAN; LEWY BODY; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; VOXEL BASED MORPHOMETRY;

EID: 84893515399     PISSN: 22815872     EISSN: 22817565     Source Type: Journal    
DOI: 10.1007/s40336-013-0029-8     Document Type: Review

References (85)

1. Perani D (2008) Functional neuroimaging of cognition. Handbook of Clinical Neurology, vol. 88 (3rd series). In: Goldenberg G, Miller B (eds) Neuropsychology and behavioral neurology. Elsevier, Philadelphia, pp 61-111.
2. Price CJ (2012) A review and synthesis of the first 20 years of PET and fMRI studies of heard speech, spoken language and reading. Neuroimage 62: 816-847.
3. Magistretti PJ (2000) Cellular bases of functional brain imaging: insights from neuron-glia metabolic coupling. Brain Res 886: 108-112.
4. Schroeter ML, Stein T, Maslowski N, Neumann J (2009) Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patients. Neuroimage 47: 1196-1206.
5. Rabinovici GD, Miller BL (2010) Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management. CNS Drugs 24: 375-398.
6. Salmon E, Garraux G, Delbeuck X, Collette F, Kalbe E, Zuendorf G, Perani D, Fazio F, Herholz K (2003) Predominant ventromedial frontopolar metabolic impairment in frontotemporal dementia. Neuroimage 20: 435-440.
7. Franceschi M, Anchisi D, Pelati O, Zuffi M, Matarrese M, Moresco RM et al (2005) Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration. Ann Neurol 57: 216-225.
8. Josephs KA, Duffy JR, Fossett TR, Strand EA, Claassen DO, Whitwell JL et al (2010) Fluorodeoxyglucose F18 positron emission tomography in progressive apraxia of speech and primary progressive aphasia variants. Arch Neurol 67: 596-605.
9. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 65: 1863-1872.
10. Dubois B, Feldman HH, Jacova C, Cummings JL, DeKosky ST, Barberger-Gateau P et al (2010) Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol 9: 1118-1127.
11. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH (2011) The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7: 263-269.
12. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC et al (2011) The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7: 270-279.
13. Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM et al (2011) Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7: 280-292.
14. Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J et al (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134: 2456-2477.
15. Herholz K, Salmon E, Perani D, Baron JC, Holthoff V, Frölich L et al (2002) Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage 17: 302-316.
16. Jeong Y, Cho SS, Park JM, Kang SJ, Lee JS, Kang E et al (2005) 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients. J Nucl Med 46: 233-239.
17. Foster NL, Heidebrink JL, Clark CM, Jagust WJ, Arnold SE, Barbas NR et al (2007) FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain 130: 2616-2635.
18. Anchisi D, Borroni B, Franceschi M, Kerrouche N, Kalbe E, Beuthien-Beumann B et al (2005) Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Arch Neurol 62: 1728-1733.
19. Mosconi L, Tsui WH, Herholz K, Pupi A, Drzezga A, Lucignani G et al (2008) Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J Nucl Med 49: 390-398.
20. Herholz K (2010) Cerebral glucose metabolism in preclinical and prodromal Alzheimer's disease. Expert Rev Neurother 10: 1667-1673.
21. Mosconi L, Mistur R, Switalski R, Tsui WH, Glodzik L, Li Y et al (2009) FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer's disease. Eur J Nucl Med Mol Imaging 36: 811-822.
22. Juh R, Pae CU, Kim TS, Lee CU, Choe B, Suh T (2005) Cerebral glucose metabolism in corticobasal degeneration comparison with progressive supranuclear palsy using statistical mapping analysis. Neurosci Lett 383: 22-27.
23. 123I]IBZM-SPECT for the differential diagnosis of parkinsonism. Neurology 79: 1314-1322.
24. Perneczky R, Drzezga A, Diehl-Schmid J et al (2006) Schooling mediates brain reserve in Alzheimer's disease: findings of fluoro-deoxy-glucose-positron emission tomography. J Neurol Neurosurg Psychiatry 77: 1060-1063.
25. Garibotto V, Borroni B, Kalbe E, Herholz K, Salmon E, Holtoff V et al (2008) Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence. Neurology 71: 1342-1349.
26. Spreng RN, Drzezga A, Diehl-Schmid J, Kurz A, Levine B, Perneczky R (2011) Relationship between occupation attributes and brain metabolism in frontotemporal dementia. Neuropsychologia 49: 3699-3703.
27. Minoshima S, Frey KA, Koeppe RA et al (1995) A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 36: 1238-1248.
28. Signorini M, Paulesu E, Friston K et al (1999) Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: a clinical validation of statistical parametric mapping. Neuroimage 9: 63-80.
29. Caroli A, Prestia A, Chen K, Ayutyanont N, Landau SM, Madison CM, Haense C, Herholz K, Nobili F, Reiman EM, Jagust WJ, Frisoni GB, EADC-PET Consortium, NEST-DD, and Alzheimer's Disease Neuroimaging Initiative (2012) Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: head-to-head comparison. J Nucl Med 53: 592-600.
30. Mosconi L (2005) Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease: FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging 32: 486-510.
31. Patterson JC, Lilien DL, Takalkar A, Pinkston JB (2011) Early detection of brain pathology suggestive of early AD using objective evaluation of FDG-PET scans. Int J Alzheimers Dis. doi: 10. 4061/2011/946590.
32. Garibotto V, Forster S, Haller S, Vargas MI, Drzezga A (2013) Molecular neuroimaging with PET/MRI. Clin Transl Imaging 1: 53-64.
33. Teune LK, Bartels AL, De Jong BM, Willemsen ATM, Eshuis SA, De Vries JJ et al (2010) Typical cerebral metabolic patterns in neurodegenerative brain diseases. Mov Disord 25: 2395-2404.
34. 18F]FDG PET brain metabolic abnormalities in single subjects (P03. 106). Neurology 78(Abstracts 1): P03. 106.
35. Landau SM, Harvey D, Madison CM et al (2011) Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging 32: 1207-1218.
36. Haxby JV, Grady CL, Koss E, Horwitz B, Heston L, Schapiro M et al (1990) Longitudinal study of cerebral metabolic asymmetries and associated neurophysiological patterns in early dementia of the Alzheimer type. Arch Neurol 47: 753-760.
37. Chételat G, Landeau B, Salmon E, Yakushev I, Bahri MA, Mézenge F et al (2013) Relationships between brain metabolism decrease in normal aging and changes in structural and functional connectivity. Neuroimage 76: 167-177.
38. Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82: 239-259.
39. Morbelli S, Piccardo A, Villavecchia G, Dessi B, Brugnolo A, Piccini A, Caroli A, Frisoni G, Rodriguez G, Nobili F (2010) Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study. Eur J Nucl Med Mol Imaging 37: 36-45.
40. Villain N, Desgranges B, Viader F, de la Sayette V, Mézenge F, Landeau B, Baron JC, Eustache F, Chételat G (2008) Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease. J Neurosci 28: 6174-6181.
41. Mosconi L, Tsui WH, De Santi S et al (2005) Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis. Neurology 64: 1860-1867.
42. Salmon E, Collette F, Degueldre C, Lemaire C, Franck G (2000) Voxel-based analysis of confounding effects of age and dementia severity on cerebral metabolism in Alzheimer's disease. Hum Brain Mapp 10: 39-48.
43. Hirao K, Ohnishi T, Matsuda H, Nemoto K, Hirata Y, Yamashita F et al (2006) Functional interactions between entorhinal cortex and posterior cingulate cortex at the very early stage of Alzheimer's disease using brain perfusion single-photon emission computed tomography. Nucl Med Commun 27: 151-156.
44. Perani D, Bressi S, Cappa SF et al (1993) Evidence of multiple memory systems in the human brain. A [18F] FDG PET metabolic study. Brain 116: 903-919.
45. Desgranges B, Baron J-, Lalevée C, Giffard B, Viader F, De La Sayette V et al (2002) The neural substrates of episodic memory impairment in Alzheimer's disease as revealed by FDG-PET: relationship to degree of deterioration. Brain 125: 1116-1124.
46. Frisch S, Dukart J, Vogt B, Horstmann A, Becker G, Villringer A et al (2013) Dissociating memory networks in early Alzheimer's disease and frontotemporal lobar degeneration-a combined study of hypometabolism and atrophy. PLoS One 8: e55251. doi: 10. 1371/journal. pone. 0055251.
47. Jagust W, Reed B, Mungas D, Ellis W, DeCarli C (2007) What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? Neurology 69: 871-877.
48. Jack CR Jr, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD, Lesnick TG, Pankratz VS, Donohue MC, Trojanowski JQ (2013) Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 12: 207-216.
49. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B (2001) Current concepts in mild cognitive impairment. Arch Neurol 58: 1985-1992.
50. Gainotti G (2010) Origins, controversies and recent developments of the MCI construct. Curr Alzheimer Res 7: 271-279.
51. Gabryelewicz T, Styczynska M, Luczywek E, Barczak A, Pfeffer A, Androsiuk W, Chodakowska-Zebrowska M, Wasiak B, Peplonska B, Barcikowska M (2007) The rate of conversion of mild cognitive impairment to dementia: predictive role of depression. Int J Geriatr Psychiatry 22: 563-567.
52. Clerici F, Del Sole A, Chiti A et al (2009) Differences in hippocampal metabolism between amnestic and non-amnestic MCI subjects: automated FDG-PET image analysis. Q J Nucl Med Mol Imaging 53: 646-657.
53. Jauhiainen AM, Kangasmaa T, Rusanen M et al (2008) Differential hypometabolism patterns according to mild cognitive impairment subtypes. Dement Geriatr Cogn Disord 26: 490-498.
54. Yuan Y, Gu ZX, Wei WS (2009) Fluorodeoxyglucose-positron-emission tomography, single-photon emission tomography, and structural MR imaging for prediction of rapid conversion to Alzheimer disease in patients with mild cognitive impairment: a meta-analysis. AJNR Am J Neuroradiol 30: 404-410.
55. Silverman DH, Truong CT, Kim SK et al (2003) Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PET. Mol Genet Metab 80: 350-355.
56. Crutch SJ, Lehmann M, Schott JM, Rabinovici GD, Rossor MN, Fox NC (2012) Posterior cortical atrophy. Lancet Neurol 11: 170-178.
57. Kas A, de Souza LC, Samri D et al (2011) Neural correlates of cognitive impairment in posterior cortical atrophy. Brain 134: 1464-1478.
58. Nestor PJ, Caine D, Fryer TD, Clarke J, Hodges JR (2003) The topography of metabolic deficits in posterior cortical atrophy (the visual variant of Alzheimer's disease) with FDG-PET. J Neurol Neurosurg Psychiatry 74: 1521-1529.
59. Verghese J, Crystal HA, Dickson DW, Lipton RB (1999) Validity of clinical criteria for the diagnosis of dementia with Lewy bodies. Neurology 53: 1974-1982.
60. Garibotto V, Montandon ML, Viaud CT, Allaoua M, Assal F, Burkhard PR et al (2013) Regions of interest-based discriminant analysis of DaTSCAN SPECT and FDG-PET for the classification of dementia. Clin Nucl Med 38: e112-e117.
61. Minoshima S, Foster NL, Petrie EC, Albin RL, Frey KA, Kuhl DE (2002) Neuroimaging in dementia with Lewy bodies: metabolism, neurochemistry, and morphology. J Geriatr Psychiatry Neurol 15: 200-209.
62. Ishii K, Imamura T, Sasaki M, Yamaji S, Sakamoto S, Kitagaki H, Hashimoto M, Hirono N, Shimomura T, Mori E (1998) Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Neurology 51: 125-130.
63. Imamura T, Ishii K, Hirono N et al (1999) Visual hallucinations and regional cerebral metabolism in dementia with Lewy bodies (DLB). Neuroreport 10: 1903-1907.
64. Imamura T, Ishii K, Sasaki M et al (1997) Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease: a comparative study using positron emission tomography. Neurosci Lett 235: 49-52.
65. Lim SM, Katsifis A, Villemagne VL, Best R, Jones G, Saling M, Bradshaw J, Merory J, Woodward M, Hopwood M, Rowe CC (2009) The 18F-FDG PET cingulate island sign and comparison to 123I-beta-CIT SPECT for diagnosis of dementia with Lewy bodies. J Nucl Med 50: 1638-1645.
66. Neary D, Snowden JS, Gustafson L et al (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51: 1546-1554.
67. Piguet O, Hornberger M, Mioshi E, Hodges JR (2011) Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management. Lancet Neurol 10: 162-172.
68. McCloskey MS, Phan KL, Coccaro EF (2005) Neuroimaging and personality disorders. Curr Psychiatry Rep 7: 65-72.
69. Kipps CM, Hodges JR, Fryer TD, Nestor PJ (2009) Combined magnetic resonance imaging and positron emission tomography brain imaging in behavioural variant frontotemporal degeneration: refining the clinical phenotype. Brain 132: 2566-2578.
70. Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, Ogar JM, Rohrer JD, Black S, Boeve BF, Manes F, Dronkers NF, Vandenberghe R, Rascovsky K, Patterson K, Miller BL, Knopman DS, Hodges JR, Mesulam MM, Grossman M (2011) Classification of primary progressive aphasia and its variants. Neurology 76: 1006-1014.
71. Grossman M (2012) The non-fluent/agrammatic variant of primary progressive aphasia. Lancet Neurol 11: 545-555.
72. Rabinovici GD, Jagust WJ, Furst AJ, Ogar JM, Racine CA, Mormino EC, O'Neil JP, Lal RA, Dronkers NF, Miller BL, Gorno-Tempini ML (2008) A beta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol 64: 388-401.
73. Hodges JR, Patterson K, Oxbury S, Funnell E (1992) Semantic dementia. Progressive fluent aphasia with temporal lobe atrophy. Brain 115: 1783-1806.
74. Desgranges B, Matuszewski V, Piolino P, Chételat G, Mézenge F, Landeau B, de la Sayette V et al (2007) Anatomical and functional alterations in semantic dementia: a voxel-based MRI and PET study. Neurobiol Aging 28: 1904-1913.
75. Drzezga A, Grimmer T, Henriksen G, Stangier I, Perneczky R, Diehl-Schmid J, Mathis CA et al (2008) Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease. Neuroimage 39: 619-633.
76. Gorno-Tempini ML, Dronkers NF, Rankin KP, Ogar JM, La Phengrasamy BA, Rosen HJ, Johnson JK, Weiner MW, Miller BL (2004) Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 55: 335-346.
77. Madhavan A, Whitwell JL, Weigand SD, Duffy JR, Strand EA, Machulda MM, Tosakulwong N, Senjem ML, Gunter JL, Lowe VJ, Petersen RC, Jack CR Jr, Josephs KA (2013) FDG PET and MRI in logopenic primary progressive aphasia versus dementia of the Alzheimer's type. PLoS One 8: e62471.
78. Gil-Navarro S, Lladó A, Rami L, Castellví M, Bosch B, Bargalló N et al (2013) Neuroimaging and biochemical markers in the three variants of primary progressive aphasia. Dement Geriatr Cogn Disord 35: 106-117.
79. Cavanna AE, Trimble MR (2006) The precuneus: a review of its functional anatomy and behavioural correlates. Brain 129: 564-583.
80. Morbelli S, Perneczky R, Drzezga A, Frisoni GB, Caroli A, van Berckel BNM et al (2013) Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer disease consortium project. J Nucl Med 54: 894-902.
81. Garibotto V, Borroni B, Sorbi S, Cappa SF, Padovani A, Perani D (2012) Education and occupation provide reserve in both ApoE ε4 carrier and noncarrier patients with probable Alzheimer's disease. Neurol Sci 33: 1037-1042.
82. Perneczky R, Häussermann P, Drzezga A, Boecker H, Granert O, Feurer R, Förstl H, Kurz A (2009) Fluoro-deoxy-glucose positron emission tomography correlates of impaired activities of daily living in dementia with Lewy bodies: implications for cognitive reserve. Am J Geriatr Psychiatry 17: 188-195.
83. Rönnemaa E, Zethelius B, Lannfelt L, Kilander L (2011) Vascular risk factors and dementia: 40-year follow-up of a population-based cohort. Dement Geriatr Cogn Disord 31: 460-466.
84. Jadhav AP, Jovin TG (2012) Vascular imaging of the head and neck. Semin Neurol 32: 401-410.
85. Gurol ME, Dierksen G, Betensky R et al (2012) Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy. Neurology 79: 320-326.